https://www.selleckchem.com/pr....oducts/valaciclovir-
Objective This study aimed at assessing the oral prevalence ofCandida species in cystic fibrosis patients and the antifungal susceptibility of the isolates. Design One hundred patients aged 3-20 years old were included in the study and were divided into three groups G1 (low severity disease) 25 cystic fibrosis patients with Shwachman-Kulczycki score (SK) between 100 and 71; G2 (high severity disease) 25 cystic fibrosis patients with SK score under 40; and G3 (control) 50 healthy patients age- and gender-matched to cystic fibros
Like
Comment
Share
